Explore 3 Stock Ideas & Industry Insights Download Free Report

Premium

Gold, Silver and Copper Slip While Oil Extends Gains on Supply Risks

Oil Market Shock: Supply Risks Drive Energy Prices Higher

Nitish Kishor | 19 March 2026

US Sector Momentum Analysis: Defensive Flight Amidst Growth Volatility

The US equity market on March 18, 2026, is witnessing a significant structural shift. As volatility increases, the "risk-on" appetite that previously fueled Technology and Discretionary sectors is being replaced by a defensive crouch. The Relative Rotation Graph highlights a market that is increasingly …

Robert Luong | 18 March 2026

US Sector Analysis: Broad Market Retreat as Yield Pressures Weigh on Growth

The US equity market faced a challenging session on March 18, 2026, characterized by a sea of red across all major sectors. While the market had recently seen a "Hormuz reprieve" cooling energy prices, the latest data reveals a shift toward risk-aversion, with defensive …

Robert Luong | 18 March 2026

Neo-Concept (NASDAQ:NCI) Stock Analysis- International's Retail Expansion Against Declining Revenues

Key HighlightsNCI stock down 16.69% to $5.19 despite $8.1M February 2026 equity offering for business expansionH1 2025 revenue declined 24% YoY to $7.7M, signaling weakness in apparel and design services segmentsCompany expanding les 100 ciels retail brand internationally with Abu Dhabi flagship and MENA …

Team Kalkine | 17 March 2026

P3 Health Partners (NASDAQ:PIII) Stock Analysis: Path to Profitability Amid Margin Pressures

Key HighlightsPIII stock down 14.14% to $2.61 despite 18% full-year 2024 revenue growth to $1.5 billionCompany faced severe medical margin compression in 2024 with 37% YoY decline to $85.5M despite 18% revenue growthManagement targeting $130M+ EBITDA improvement through operational efficiencies and contract rationalization2025 guidance …

Team Kalkine | 17 March 2026

LeonaBio (NASDAQ:LONA) Surges 34% on Name Change and Transformational Phase 3 Breast Cancer Program

Key HighlightsLONA stock rallies 34.20% to $11.30 following company name change to LeonaBio and announcement of transformational Phase 3 programCompany acquired rights to Phase 3 lasofoxifene program for treatment-resistant metastatic breast cancer in December 2025 transactionRecently appointed Mark F. Kubik as Chief Business Officer …

Team Kalkine | 17 March 2026

US Sector Momentum Analysis: Growth Rebound and Defensive Exhaustion

The US equity market is currently defined by a stark divergence between AI-driven growth and interest-rate-sensitive defensives. While rising Treasury yields pose a significant "duration risk" to broader indices, institutional capital is finding sanctuary in the mega-cap stability of Communication Services (XLC) and the …

Robert Luong | 17 March 2026

US Market Analysis: Treasury Yield Surge Rattles Defensive and Tech Sectors

The US equity market faced a significant technical hurdle on Thursday, March 12, 2026, as a dramatic spike in global oil prices and climbing Treasury yields triggered a sharp reversal in investor sentiment. While the broader S&P 500 tumbled 1.5%, the session highlighted a …

Robert Luong | 17 March 2026

A Giant Prepares to List: SpaceX

A Landmark Event for Global Capital Markets

Nitish Kishor | 17 March 2026